Underwriting Agreements in the Health Care Equipment & Supplies Industry

751 Contracts & Agreements

Browse by Company

ABIOMED Inc (1 contract)
Accelerate Diagnostics, Inc (2)
Acrivon Therapeutics, Inc. (1)
Acutus Medical, Inc. (2)
Adams Respiratory Therapeutics, Inc. (1)
AETHLON MEDICAL INC (2)
AIRXPANDERS INC (1)
AIT Therapeutics, Inc. (2)
Alphatec Holdings, Inc. (3)
Angiodynamics Inc (3)
ANTARES PHARMA, INC. (3)
Apogee Therapeutics, Inc. (1)
Apollo Endosurgery, Inc. (3)
Apyx Medical Corp (2)
AquaMed Technologies, Inc. (2)
ARATANA THERAPEUTICS, INC. (1)
Arch Therapeutics, Inc. (3)
ARGOS THERAPEUTICS INC (2)
AtriCure, Inc. (3)
Audentes Therapeutics, Inc. (4)
Autolus Therapeutics plc (1)
Avinger Inc (15)
AxoGen, Inc. (5)
Axonics Modulation Technologies, Inc. (5)
BARRIER THERAPEUTICS INC (1)
Bausch & Lomb Corp (1)
Baxter International Inc. (1)
Becton Dickinson (22)
Becton Dickinson Euro Finance S.a. r.l. (1)
Bellerophon Therapeutics, Inc. (3)
BIOLASE, INC (11)
BIOLIFE SOLUTIONS INC (1)
BIOMERICA INC (1)
BIOMIMETIC THERAPEUTICS, INC. (1)
Bionik Laboratories Corp. (2)
BioSig Technologies, Inc. (3)
Bioventus Inc. (2)
Bluejay Diagnostics, Inc. (1)
Boston Scientific (12)
BRAIN SCIENTIFIC INC. (1)
Cadrenal Therapeutics, Inc. (4)
Cardiovascular Systems Inc (6)
CARGO Therapeutics, Inc. (1)
Cascadian Therapeutics, Inc. (8)
Centrexion Therapeutics Corp (2)
CERUS CORP (6)
CESCA THERAPEUTICS INC. (1)
Chelsea Therapeutics International, Ltd. (4)
CHEMBIO DIAGNOSTICS, INC. (5)
CHF Solutions, Inc. (19)
Chromocell Therapeutics Corp (5)
Civitas Therapeutics, Inc. (1)
CLARUS THERAPEUTICS INC (2)
Co-Diagnostics, Inc. (3)
Colfax CORP (6)
Conformis Inc (3)
CORNERSTONE THERAPEUTICS INC (1)
Coya Therapeutics, Inc. (1)
Cryoport, Inc. (5)
Cue Health Inc. (1)
CVRx, Inc. (1)
Cytosorbents Corp (5)
D8 Holdings Corp. (3)
Danaher Corp. (13)
Dare Bioscience, Inc. (4)
DarioHealth Corp. (4)
DELCATH SYSTEMS, INC. (12)
Dentsply Sirona (2)
DEXCOM INC (2)
Dimension Therapeutics, Inc. (1)
Durata Therapeutics, Inc. (2)
Eargo, Inc. (1)
Echo Therapeutics, Inc. (2)
Edwards Lifesciences (2)
EKSO BIONICS HOLDINGS, INC. (3)
electroCore, Inc. (3)
Elicio Therapeutics, Inc. (1)
EMULATE THERAPEUTICS, INC. (2)
ENDOLOGIX INC (3)
ENDRA Life Sciences Inc. (8)
Envista Holdings Corp (1)
ESTABLISHMENT LABS HOLDINGS INC. (3)
Felicitex Therapeutics Inc. (2)
FEMASYS INC (1)
FIGS, Inc. (2)
GenMark Diagnostics, Inc. (2)
GLAUKOS Corp (1)
Globus Medical Inc. (1)
Glucose Biosensor Systems (Greater China) Holdings, Inc. (5)
GUIDED THERAPEUTICS INC (2)
Hancock Jaffe Laboratories, Inc. (6)
HealthCor Catalio Acquisition Corp. (3)
Heart Test Laboratories, Inc. (2)
HELIUS MEDICAL TECHNOLOGIES, INC. (7)
Heska Corporation (1)
Hill-Rom Holdings Inc. (1)
HYPERION THERAPEUTICS INC (2)
Inari Medical, Inc. (2)
Innovative Eyewear Inc (4)
Inogen, Inc. (1)
InspireMD, Inc. (10)
INSULET CORP (5)
Insys Therapeutics, Inc. (2)
INTARCIA THERAPEUTICS, INC (1)
Integra Lifesciences Holdings (3)
INTENSITY THERAPEUTICS, INC. (8)
INTRICON CORP (1)
Invea Therapeutics, Inc (1)
INVIVO THERAPEUTICS HOLDINGS CORP. (4)
INVO Bioscience, Inc. (3)
IRADIMED CORP (2)
iRhythm Technologies, Inc. (5)
IRIDEX CORP (2)
Juno Therapeutics, Inc. (2)
Kyverna Therapeutics, Inc. (1)
Lantheus Holdings, Inc. (5)
LeMaitre Vascular, Inc. (2)
Lexeo Therapeutics, Inc. (1)
LivaNova (1)
Longview Acquisition Corp. (2)
Lucid Diagnostics Inc. (1)
Lucira Health, Inc. (1)
MABVAX THERAPEUTICS HOLDINGS, INC. (7)
Medtronic plc (5)
MELINTA THERAPEUTICS, INC. (5)
Merit Medical Systems, Inc. (2)
MESA LABORATORIES INC (3)
Microbot Medical Inc. (5)
MILESTONE SCIENTIFIC INC. (5)
Mineralys Therapeutics, Inc. (1)
MINERVA SURGICAL INC (1)
MISONIX INC (1)
Modular Medical, Inc. (6)
Motus GI Holdings, Inc. (4)
MRI INTERVENTIONS, INC. (6)
MYOMO INC (5)
NanoVibronix, Inc. (6)
Neumora Therapeutics, Inc. (1)
NeuroMetrix, Inc. (3)
Neuronetics, Inc. (2)
NEUROONE MEDICAL TECHNOLOGIES Corp (2)
NeuroPace Inc (1)
NEVRO CORP (5)
NEXEON MEDSYSTEMS INC (2)
NovoCure Ltd (1)
NuVasive Inc (2)
OBALON THERAPEUTICS INC (6)
Ocata Therapeutics, Inc. (1)
Ocera Therapeutics, Inc. (3)
OraSure Technologies, Inc. (2)
Orexigen Therapeutics, Inc. (1)
Ortho Clinical Diagnostics Holdings plc (2)
ORTHOPEDIATRICS CORP (5)
Outset Medical, Inc. (4)
Oxford Immunotec Global PLC (2)
Pandion Therapeutics Holdco LLC (1)
Paragon 28, Inc. (2)
PAVmed Inc. (2)
Peloton Therapeutics, Inc. (1)
Penumbra Inc (3)
PERNIX THERAPEUTICS HOLDINGS, INC. (1)
PetVivo Holdings, Inc. (2)
Precision Therapeutics Inc. (4)
Presbia PLC (3)
PROCEPT BioRobotics Corp (2)
Pulmonx Corp (1)
Pulse Biosciences, Inc. (2)
QUIDEL CORP (1)
Quotient Ltd (9)
Ra Medical Systems, Inc. (4)
REPROS THERAPEUTICS INC. (4)
ReShape Lifesciences Inc. (5)
Restoration Robotics, Inc. (3)
ReWalk Robotics Ltd. (3)
ROCKWELL MEDICAL, INC. (4)
RTI Surgical Holdings, Inc. (2)
RxSight, Inc. (3)
Sandbridge Acquisition Corp (3)
SeaSpine Holdings Corp (3)
SECOND SIGHT MEDICAL PRODUCTS INC (3)
Semler Scientific, Inc. (1)
Senseonics Holdings, Inc. (6)
Sensus Healthcare, Inc. (3)
Sharps Technology Inc. (3)
ShockWave Medical, Inc. (3)
SI-BONE, Inc. (4)
Sientra, Inc. (4)
Sight Sciences, Inc. (1)
Silk Road Medical Inc (6)
Sintx Technologies, Inc. (6)
SIRNA THERAPEUTICS INC (1)
SmileDirectClub, Inc. (1)
Sonendo, Inc. (1)
Spark Therapeutics, Inc. (4)
STAAR SURGICAL CO (2)
STEMLINE THERAPEUTICS INC (8)
Stereotaxis, Inc. (3)
STERIS Ltd (1)
STRATA Skin Sciences, Inc. (3)
Structure Therapeutics Inc. (1)
Stryker Corp. (9)
TACTILE SYSTEMS TECHNOLOGY INC (1)
Talis Biomedical Corp (1)
TANDEM DIABETES CARE INC (6)
TELA Bio, Inc. (4)
Teleflex Inc (2)
Tenon Medical, Inc. (3)
Tivic Health Systems, Inc. (6)
Tobira Therapeutics, Inc. (4)
TRANSENTERIX INC. (7)
TransMedics Group, Inc. (3)
TREACE MEDICAL CONCEPTS, INC. (2)
Trius Therapeutics Inc (4)
Valeritas Holdings Inc. (3)
VAPOTHERM INC (3)
VERMILLION, INC. (7)
ViewRay, Inc. (6)
VIVEVE MEDICAL, INC. (9)
VOLITIONRX LTD (9)
WOUND MANAGEMENT TECHNOLOGIES, INC. (1)
Zimmer Biomet Holdings (11)
Zosano Pharma Corp (7)
ZYNEX INC (1)

Recent Contracts

Underwriting Agreement, dated as of February 28, 2024, by and between ClearPoint Neuro, Inc. and Lake Street Capital Markets, LLC, as representative of the several underwriters... (MRI INTERVENTIONS, INC., Filed With SEC on March 1, 2024)
Underwriting Agreement, dated as of February 22, 2024, as supplemented by the Terms Agreement, dated February 22, 2024, among American Medical Systems Europe B.V., Boston... (Boston Scientific, Filed With SEC on February 27, 2024)
Letter Agreement to Underwriting Agreement, dated as of February 16, 2024, between the Company and A.G.P./Alliance Global Partners, as Representative of the Underwriters (Chromocell Therapeutics Corp, Filed With SEC on February 22, 2024)
Underwriting Agreement, dated February 15, 2024, between the Company and A.G.P./Alliance Global Partners, as Representative of the Underwriters (Chromocell Therapeutics Corp, Filed With SEC on February 22, 2024)
Underwriting Agreement dated as of February 15, 2024 between the Company and Titan Partners Group LLC (Modular Medical, Inc., Filed With SEC on February 16, 2024)
Underwriting Agreement, dated as of February 8, 2024, by and among the Company, Jefferies LLC and Truist Securities, Inc., as representatives of the several underwriters named... (Autolus Therapeutics plc, Filed With SEC on February 8, 2024)
Underwriting Agreement, dated February 5, 2024, by and among Becton, Dickinson and Company and Barclays Bank PLC, BNP Paribas, Citigroup Global Markets Limited, J.P. Morgan... (Becton Dickinson, Filed With SEC on February 6, 2024)
Underwriting Agreement, dated February 5, 2024, by and among Becton, Dickinson and Company and Barclays Capital Inc., BNP Paribas Securities Corp., Citigroup Global Markets Inc.,... (Becton Dickinson, Filed With SEC on February 6, 2024)
Form of Underwriting Agreement (Kyverna Therapeutics, Inc., Filed With SEC on February 1, 2024)
Form of Underwriting Agreement (Chromocell Therapeutics Corp, Filed With SEC on January 30, 2024)
Form of Underwriting Agreement (Accelerate Diagnostics, Inc, Filed With SEC on January 16, 2024)
Form of Underwriting Agreement (Invea Therapeutics, Inc, Filed With SEC on January 12, 2024)
Underwriting Agreement, dated as of December 10, 2023 between the Company and Maxim Group LLC, as underwriter (MILESTONE SCIENTIFIC INC., Filed With SEC on December 12, 2023)
Underwriting Agreement, dated December 6, 2023, between Stryker Corporation and Barclays Bank PLC, Goldman Sachs & Co. LLC, Mizuho International plc and Wells Fargo Securities... (Stryker Corp., Filed With SEC on December 11, 2023)
Underwriting Agreement, dated December 5, 2023, between Stryker Corporation and Citigroup Global Markets Inc., BNP Paribas Securities Corp., BofA Securities, Inc. and U.S. Bancorp... (Stryker Corp., Filed With SEC on December 8, 2023)
Underwriting Agreement, dated as of November 28, 2023, among Zimmer Biomet Holdings, Inc., Barclays Capital Inc., Goldman Sachs & Co. LLC, Mizuho Securities USA LLC and Morgan... (Zimmer Biomet Holdings, Filed With SEC on December 1, 2023)
Form of Underwriting Agreement (Arch Therapeutics, Inc., Filed With SEC on November 9, 2023)
Form of Underwriting Agreement (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
Form of Underwriting Agreement (Lexeo Therapeutics, Inc., Filed With SEC on October 30, 2023)
Form of Underwriting Agreement (Chromocell Therapeutics Corp, Filed With SEC on October 16, 2023)
Form of Underwriting Agreement (Arch Therapeutics, Inc., Filed With SEC on October 5, 2023)
Underwriting Agreement dated as of October 2, 2023, by and between Intelligent Bio Solutions Inc. and Ladenburg Thalmann & Co. Inc (Glucose Biosensor Systems (Greater China) Holdings, Inc., Filed With SEC on October 4, 2023)
Form of Underwriting Agreement between Intelligent Bio Solutions Inc. and Ladenburg Thalmann & Co. Inc (Glucose Biosensor Systems (Greater China) Holdings, Inc., Filed With SEC on September 22, 2023)
Underwriting Agreement, dated September 13, 2023, by and among BIOLASE, Inc., Lake Street Capital Markets, LLC and Maxim Group LLC, as representatives of the several underwriters... (BIOLASE, INC, Filed With SEC on September 18, 2023)
Form of Underwriting Agreement (Neumora Therapeutics, Inc., Filed With SEC on September 11, 2023)
Form of Underwriting Agreement between Intelligent Bio Solutions Inc. and Ladenburg Thalmann & Co. Inc (Glucose Biosensor Systems (Greater China) Holdings, Inc., Filed With SEC on September 11, 2023)
Form of Underwriting Agreement (Chromocell Therapeutics Corp, Filed With SEC on September 1, 2023)
Form of Underwriting Agreement (BIOLASE, INC, Filed With SEC on August 30, 2023)
Underwriting Agreement, dated August 2, 2023, by and among the Company and Morgan Stanley & Co. LLC and Cowen and Company, LLC, as representatives of the several underwriters... (D8 Holdings Corp., Filed With SEC on August 4, 2023)
Underwriting Agreement, dated as of August 1, 2023, by and among PROCEPT BioRobotics Corporation and BofA Securities, Inc., Piper Sandler & Co. and Cowen and Company, LLC, as... (PROCEPT BioRobotics Corp, Filed With SEC on August 4, 2023)
Underwriting Agreement, dated July 24, 2023, between NeuroOne Medical Technologies Corporation and The Benchmark Company, LLC (NEUROONE MEDICAL TECHNOLOGIES Corp, Filed With SEC on July 27, 2023)
Underwriting Agreement, dated June 29, 2023 (INTENSITY THERAPEUTICS, INC., Filed With SEC on July 5, 2023)
Form of Underwriting Agreement (Apogee Therapeutics, Inc., Filed With SEC on July 3, 2023)
Underwriting Agreement, dated June 1, 2023, by and between VolitionRx Limited and Prime Executions, Inc. dba Freedom Capital Markets (VOLITIONRX LTD, Filed With SEC on June 5, 2023)
Underwriting Agreement, dated May 24, 2023, by and between BIOLASE, Inc. and Lake Street Capital Markets, LLC, as representative of the several underwriters named therein (BIOLASE, INC, Filed With SEC on May 26, 2023)
Form of Underwriting Agreement (BIOLASE, INC, Filed With SEC on May 24, 2023)
Form of Underwriting Agreement (BIOLASE, INC, Filed With SEC on May 22, 2023)
Form of Underwriting Agreement (BIOLASE, INC, Filed With SEC on May 18, 2023)
Form of Underwriting Agreement (INTENSITY THERAPEUTICS, INC., Filed With SEC on May 18, 2023)
Underwriting Agreement (Modular Medical, Inc., Filed With SEC on May 17, 2023)